Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 476
Filtrar
3.
Front Public Health ; 12: 1384122, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38660356

RESUMO

Background: Non-communicable diseases are a global health problem. The metric Disability-Adjusted Life Years was developed to measure its impact on health systems. This metric makes it possible to understand a disease's burden, towards defining healthcare policies. This research analysed the effect of healthcare expenditures in the evolution of disability-adjusted life years for non-communicable diseases in the European Union between 2000 and 2019. Methods: Data were collected for all 27 European Union countries from Global Burden of Disease 2019, Global Health Expenditure, and EUROSTAT databases. Econometric panel data models were used to assess the impact of healthcare expenses on the disability-adjusted life years. Only models with a coefficient of determination equal to or higher than 10% were analysed. Results: There was a decrease in the non-communicable diseases with the highest disability-adjusted life years: cardiovascular diseases (-2,952 years/105 inhabitants) and neoplasms (-618 years/105 inhabitants). Health expenditure significantly decreased disability-adjusted life years for all analysed diseases (p < 0.01) unless for musculoskeletal disorders. Private health expenditure did not show a significant effect on neurological and musculoskeletal disorders (p > 0.05) whereas public health expenditure did not significantly influence skin and subcutaneous diseases (p > 0.05). Conclusion: Health expenditure have proved to be effective in the reduction of several diseases. However, some categories such as musculoskeletal and mental disorders must be a priority for health policies in the future since, despite their low mortality, they can present high morbidity and disability.


Assuntos
Anos de Vida Ajustados pela Incapacidade , União Europeia , Gastos em Saúde , Doenças não Transmissíveis , Humanos , União Europeia/economia , União Europeia/estatística & dados numéricos , Doenças não Transmissíveis/economia , Doenças não Transmissíveis/mortalidade , Doenças não Transmissíveis/epidemiologia , Gastos em Saúde/estatística & dados numéricos , Carga Global da Doença , Masculino , Feminino , Efeitos Psicossociais da Doença , Pessoas com Deficiência/estatística & dados numéricos
7.
PLoS One ; 16(8): e0256242, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34428244

RESUMO

Generally, research and studies about commodities focus on price trends, analysis in terms of international competitiveness, market position structure, rate of net exports, market share, and concentration index. This paper has developed an analysis of the most influential agricultural commodities traded from Colombia to European Union, which are bananas, coffee, and palm oil. Analyzing the economic and commercial effects in two traditional agricultural commodities from Colombia (bananas and coffee) with the rise of palm oil as a commodity in the trade relation with its partner; the European Union. The structure draws from the overview of general aspects and the behavior of Colombian foreign trade, as diversification of export products and trade partners, to focus on the characteristics of the trade relationship between the European Union and Colombia. The aim is analyze the proportional relation between bananas, coffee, and palm oil exported to the EU, according to three indicators, the volume of production, exports share, and trade value, from 2008 until 2019, identifying the trends before and after the implementation of the free trade agreement. Finally, with the coefficient correlation, determine the agricultural commodity that has the strongest and positive relationship with the total agricultural exports value from Colombia to the European Union.


Assuntos
Café/economia , Comércio/economia , União Europeia/economia , Óleo de Palmeira/economia , Agricultura/economia , Colômbia , Comércio/legislação & jurisprudência , Humanos , Musa
8.
PLoS One ; 16(7): e0254993, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34293023

RESUMO

One of the main reasons for the dynamic global economic development observed in recent years is the process of digitalization, referred to as Industry 4.0. The significance of digitalization for this development is appreciated by the EU-27. In order for these actions to be effective, it is necessary to diagnose the current level of digitalization in the EU-27countries. The article presents the results of the assessment of the level of digitalization of enterprises in the EU-27 countries. An empirical analysis was conducted using 16 determinants which describe the digitalization in a sample of 27 EU countries. Based on the adopted criteria and the Technique for Order Preference by Similarity to an Ideal Solution method, these countries were divided into four classes in terms of the level of digitalization. The analysis looked at the size of enterprises and was performed independently for small, medium and large enterprises. The adopted indicators allowed for the analysis of similarity between the EU-27 countries in terms of digitalization, using the Kohonen's networks. The result of this research was the division of the EU-27 countries into groups, also taking into account the size of studied enterprises. Due to the immensely diverse EU-27 economy, such a huge undertaking as the digital transformation process requires building logical internal "digital coalitions". The designated assessment and similarity between countries creates such opportunities, also in terms of building an effective policy to support these processes by the EU. This increases the chances of success of joint ventures and building a sustainable European community based on the latest technologies.


Assuntos
União Europeia/economia , Indústrias/economia , Robótica/educação
9.
PLoS One ; 16(5): e0250867, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33939759

RESUMO

Most empirical studies examining the export competitiveness of a country in a target market are undertaken by focusing on supply, only analysing the group of competing countries. In addition, if the target market to be analysed is extensive, like the European Union, it is generally analysed as a whole. This study presents an evaluation of the tomato export competitiveness, from a differentiated demand perspective, analysing its main customers markets in the context of European Union. The methodological framework is implemented through Constant Market Share to analyze variations in exports, allowing the portion attributable to competitiveness and segregation into general or specific competitiveness to be quantified. The Constant Market Share was adapted to focus on the differentiated demand so as to observe the influence of the worldwide crisis (2007/08) on the European tomato market. This study allows the analysis of profile changes into the competitor exporting economies. As a contribution to the methodology, this study presents a new graphical way of representing the results of Constant Market Share methodology by means of export competitiveness maps in the European tomato market for the group for each main competitor in each European client market. According to our results, Spain and Belgium are candidate countries to be competitive in the main European markets.


Assuntos
Competição Econômica/economia , União Europeia/economia , Marketing/economia , Solanum lycopersicum/economia , Humanos
12.
PLoS One ; 16(2): e0246886, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33606770

RESUMO

This paper studies the connectedness between oil price shocks and agricultural commodities. Our sample period ranges from January 2002 to July 2020, covering the three global crises; Global Financial Crisis, the European sovereign debt crisis and Covid-19 pandemic crisis. We employ Granger causality tests, and the static and dynamic connectedness spillover index methodology. We find that the shocks in oil prices are Granger-caused mainly by price changes of grains, live cattle, and wheat, while supply shock granger causes variations mostly in grain prices. We find that, from the point of view of static connectedness, for both, price and volatility spillovers, the livestock is the largest transmitter, while the lean hogs are the major receiver. Our dynamic analysis evidences that connectedness increases during the financial crisis period. Our results are potentially useful for investors, portfolios managers and policy makers.


Assuntos
Agricultura/economia , COVID-19/economia , Comércio/economia , Petróleo/economia , SARS-CoV-2 , COVID-19/epidemiologia , União Europeia/economia , Humanos
13.
PLoS One ; 16(2): e0245515, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33539389

RESUMO

In this article we investigate how the public communication of the Hungarian Central Bank's Monetary Council (MC) affects Hungarian sovereign bond yields. This research ties into the advances made in the financial and political economy literature which rely on extensive textual data and quantitative text analysis tools. While prior research demonstrated that forward guidance, in the form of council meeting minutes or press releases can be used as predictors of rate decisions, we are interested in whether they are able to directly influence asset returns as well. In order to capture the effect of central bank communication, we measure the latent hawkish or dovish sentiment of MC press releases from 2005 to 2019 by applying a sentiment dictionary, a staple in the text mining toolkit. Our results show that central bank forward guidance has an intra-year effect on bond yields. However, the hawkish or dovish sentiment of press releases has no impact on maturities of one year or longer where the policy rate proves to be the most important explanatory variable. Our research also contributes to the literature by applying a specialized dictionary to monetary policy as well as broadening the discussion by analyzing a case from the non-eurozone Central-Eastern region of the European Union.


Assuntos
Contabilidade , Comunicação , União Europeia/economia , Humanos , Hungria , Política , Política Pública
17.
J Health Polit Policy Law ; 46(1): 71-92, 2021 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-33085956

RESUMO

European Union (EU) fiscal governance, especially the European Semester, is an ambitious new governance architecture involving surveillance and discipline, across both Eurozone and non-Eurozone member state policies, in pursuit of fiscal rigor. It is the most recent of several attempts to expand EU powers over member state policy with the goal of austere budgeting, and one that has led to remarkable claims of authority by the EU over member state health policies as detailed as medical school admissions and the role of primary care. It is expected that it would be resisted not just by those who object to an EU role in the organization and delivery of health care but also by those who object to a particular austere approach to health policy. How well is it working? Using two waves of interviews and documentary analysis, and health as a policy case study, the authors document three key techniques that opponents use to undermine the semester's governance architecture: broadening goals, expanding the scope of conflict, and disputing and nuancing indicators. The result is that opponents of a narrow fiscal governance agenda are again successfully undermining the narrow focus of the semester.


Assuntos
União Europeia/economia , União Europeia/organização & administração , Política Fiscal , Política de Saúde , Atenção à Saúde/economia , Atenção à Saúde/organização & administração , Dissidências e Disputas , Humanos , Metáfora , Formulação de Políticas
18.
J Health Polit Policy Law ; 46(1): 117-145, 2021 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-33085959

RESUMO

Member states have consistently limited the European Union's competences in the area of health care reimbursement. Despite these efforts, there has been a slow but steady tendency toward harmonization of a key tool in reimbursement decision-making: health technology assessment (HTA), a multidisciplinary evaluation of "value for money" of medicines, devices, diagnostics, and interventions, which provides expert advice for reimbursement decisions. This article examines the origins of this paradoxical appetite for harmonization as well as of the dissensus that has, at the moment, somewhat stalled further integration in HTA. It finds that the prointegration neofunctionalist "permissive dissensus" is still present in decision making on HTA but potentially offset by dissensus or outright opposition from key actors, including member states and the medical device industry. These actors are able to decipher the potential consequences of highly technical issues, such as HTA, for national systems of social protection. Despite that, they have little interest in politicizing the issue, potentially opening the door to integrative policy solutions in the future.


Assuntos
Tomada de Decisões , União Europeia/economia , Gastos em Saúde , Política Pública/tendências , Mecanismo de Reembolso , Avaliação da Tecnologia Biomédica/economia , Dissidências e Disputas , Humanos
19.
Health Econ Policy Law ; 16(1): 64-75, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32434612

RESUMO

The paper addresses the issue of excessive price abuse under Article 102(a) of the Treaty on the Functioning of the European Union (TFEU), by drawing inspiration from a recent stream of cases (developed first at the national and then at the EU level) involving pharmaceutical companies marketing off-patent drugs. In particular, the two 'most advanced' cases are analysed: Aspen in Italy and Pfizer/Flynn in the United Kingdom. This new-found attention towards exploitative practices in the form of excessive and unfair pricing by dominant undertakings that have traditionally been subject to a cautious antitrust scrutiny seems worth exploring for a number of reasons, as illustrated in the paper. Ultimately, it is argued that this further 'interference' of competition law into the realms of regulation may be actually justified, albeit subject to precise conditions for enforcement, and may pursue policy objectives in the wider context of EU health law.


Assuntos
Leis Antitruste/economia , Comércio/legislação & jurisprudência , Custos de Medicamentos/legislação & jurisprudência , Indústria Farmacêutica/economia , Indústria Farmacêutica/legislação & jurisprudência , Competição Econômica/legislação & jurisprudência , União Europeia/economia , Humanos , Itália , Reino Unido
20.
N Biotechnol ; 60: 2-8, 2021 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-32835869

RESUMO

Bioeconomy is not an autonomous sector of the economy, but rather a complex mechanism involving agriculture, industry, biotechnology, service sectors and consumers. To measure the size of the bioeconomy in European Union (EU) countries, it is necessary to create appropriate indicators that allow it to be monitored with reference to its current state, growth rate and sector description. In many countries, including Poland, there is no complete information or data collection system to monitor bioeconomy development directly, e.g. in the Polish Central Statistical Office. In response to these needs, several groups of indicators related to the circular economy, sustainable development and Europe 2020 were created by the European Commission (EC) in the Eurostat database. These indicators can help monitoring of bioeconomy development in EU countries. The present study discusses factors for bioeconomy development through an analysis of their social, economic and environmental aspects, as well as showing the value of the selected indicators in the EU and Poland. In addition, a separate section is dedicated to public perception of bioeconomy and to legislation regarding genetically modified organisms (GMOs). To date, many research studies have been reported on the public acceptance of bioeconomy issues in the EU, including renewable resources, biofuels, GMOs, bio-based products, food security and climate change. The awareness and perception of society on the bioeconomy, bio-based products and processes, and the sustainable use of resources can contribute to environmental sustainability, but intensified efforts are required to increase public acceptance.


Assuntos
Biotecnologia/economia , Desenvolvimento Econômico , União Europeia/economia , Polônia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...